Literature DB >> 12060044

Preoperative esophageal body motility does not influence the outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease.

M Booth1, J Stratford, T C B Dehn.   

Abstract

We evaluated a policy of performing laparoscopic antireflux surgery without tailoring the procedure to the results of preoperative esophageal motility tests. A total of 117 patients (82 with normal esophageal motility; 35 with ineffective motility, IEM) underwent laparoscopic Nissen fundoplication for symptomatic gastroesophageal reflux. There were no significant differences in preoperative symptom length, dysphagia, DeMeester symptom scores, acid exposure times or lower esophageal sphincter pressures between the two groups. Both groups showed postoperative improvements in DeMeester symptom scores, dysphagia and acid exposure, with no differences between groups. At 1 year after surgery, 95% of the normal motility group and 91% of the IEM group had a good/excellent outcome from surgery. None of the IEM group required postoperative dilatation or reoperation. Patients with IEM fare equally well from laparoscopic Nissen fundoplication as those with normal esophageal motility. There is no merit in tailoring antireflux surgery to the results of preoperative motility tests.

Entities:  

Mesh:

Year:  2002        PMID: 12060044     DOI: 10.1046/j.1442-2050.2002.00229.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  11 in total

1.  Value of preoperative esophageal function studies before laparoscopic antireflux surgery.

Authors:  Walter W Chan; Laura R Haroian; C Prakash Gyawali
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

2.  Long-term experience of treating 185 patients with gastroesophageal reflux disease (GERD) by anti-reflux surgery respecting the functional-morphological restoration of the esophagus.

Authors:  R Horstmann; C Classen; S Röttgermann; M Langer; D Palmes
Journal:  Langenbecks Arch Surg       Date:  2005-11-18       Impact factor: 3.445

Review 3.  [Correct diagnosis for indication in gastroesophageal reflux disease].

Authors:  A H Hölscher; E Bollschweiler; Ch Gutschow; P Malfertheiner
Journal:  Chirurg       Date:  2005-04       Impact factor: 0.955

4.  Laparoscopic fundoplication: a 10-year learning curve.

Authors:  D Zacharoulis; C J O'Boyle; P C Sedman; W A Brough; C M S Royston
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

5.  The role of preoperative high resolution manometry in predicting dysphagia after laparoscopic Nissen fundoplication.

Authors:  Sonam Kapadia; Turner Osler; Allen Lee; Edward Borrazzo
Journal:  Surg Endosc       Date:  2017-12-12       Impact factor: 4.584

6.  Laparoscopic Nissen fundoplication is a good option in patients with abnormal esophageal motility.

Authors:  Zurab Tsereteli; Emanuel Sporn; J Andres Astudillo; Brent Miedema; William S Eubanks; Klaus Thaler
Journal:  Surg Endosc       Date:  2009-01-27       Impact factor: 4.584

7.  Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: evaluation with multichannel intraluminal impedance.

Authors:  E Quiroga; F Cuenca-Abente; D Flum; E P Dellinger; B K Oelschlager
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

8.  Esophageal manometry and clinical outcome after laparoscopic Nissen fundoplication.

Authors:  Huiqi Yang; David I Watson; Jamie Kelly; Carolyn J Lally; Jennifer C Myers; Glyn G Jamieson
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

Review 9.  Minor esophageal functional disorders: are they relevant?

Authors:  Ryan A Balko; Don C Codipilly; Karthik Ravi
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-17

Review 10.  Ineffective esophageal motility: Concepts, future directions, and conclusions from the Stanford 2018 symposium.

Authors:  C Prakash Gyawali; Daniel Sifrim; Dustin A Carlson; Mary Hawn; David A Katzka; John E Pandolfino; Roberto Penagini; Sabine Roman; Edoardo Savarino; Roger Tatum; Michel Vaezi; John O Clarke; George Triadafilopoulos
Journal:  Neurogastroenterol Motil       Date:  2019-04-11       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.